Company: INDP
Filing Date: 2025-03-13
Form Type: 10-K
Source: 0001493152-25-010136
Chunk: 217

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: 10-K
Item: Item 8
Chunk 217
---
 its purpose, our Compensation Committee has the following principal duties:

    ●
    reviewing and
    approving, or recommending for approval by the Board, our overall compensation strategy and policies, including evaluating risks
    associated with our compensation policies and practices;

    ●
    reviewing and approving,
    or recommending for approval by the Board, the compensation of our CEO and our other executive officers;

    ●
    overseeing and administering
    our cash and equity incentive plans;

    ●
    reviewing and making recommendations
    to the Board of Directors with respect to non-employee director compensation;

    ●
    reviewing and discussing
    annually with management our “Compensation Discussion and Analysis,” to the extent required; and

    ●
    preparing the annual compensation
    committee report, to the extent required by SEC rules.

The
Compensation Committee generally considers the Chief Executive Officer’s recommendations when making decisions regarding the compensation
of executive officers (other than the Chief Executive Officer). Pursuant to the Compensation Committee’s charter, which is available
on the Investors page of our website at www.indaptusrx.com, the Compensation Committee has the authority to retain or obtain the
advice of compensation consultants, legal counsel and other advisors to assist in carrying out its responsibilities. The Compensation
Committee did not engage the services of a compensation consultant in 2023.

The
Compensation Committee may delegate its authority under its charter to one or more subcommittees as it deems appropriate from time to
time. The Compensation Committee may also delegate to an officer the authority to grant equity awards to certain employees, as further
described in its charter and subject to the terms of our equity plans.

The
members of our Compensation Committee are Mr. Maddaluna and Mr. Hayes. Mr. Maddaluna serves as the Chairperson of the Compensation Committee.
Each member of the Compensation Committee qualifies as an independent director under Nasdaq’s heightened independence standards
for members of a compensation committee and as a “non-employee director” as defined in Rule 16b-3 of the Exchange Act.

Nominating
Committee

Our
Nominating Committee’s responsibilities include:

    ●
    identifying
    individuals qualified to become Board members;

    ●
    recommending to the Board
    the persons to be nominated for election as directors and to each Board committee;

    ●
    reviewing with the Chief
    Executive Officer and making recommendations to the Board with respect to our